Evidence map›Paper›PMID 26253715›Full record

ArticleStem cells translational medicine2015

Excessive Cellular Proliferation Negatively Impacts Reprogramming Efficiency of Human Fibroblasts.

Manoj K Gupta, Adrian Kee Keong Teo, Tata Nageswara Rao, Shweta Bhatt, Andre Kleinridders, Jun Shirakawa, Tomozumi Takatani, Jiang Hu, Dario F De Jesus, Rebecca Windmueller and 2 more

Open access · goldAbstract read
In one paragraph

Article in Stem cells translational medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Manoj K GuptaSections of Islet Cell and Regenerative Biology and Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA;
Adrian Kee Keong TeoSections of Islet Cell and Regenerative Biology and Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA;
Tata Nageswara RaoSections of Islet Cell and Regenerative Biology and Howard Hughes Medical Institute, Department of Stem Cell and Regenerative Biology, Harvard Stem Cell Institute, Harvard University, Cambridge, Massachusetts, USA.
Shweta BhattSections of Islet Cell and Regenerative Biology and Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA;
Andre KleinriddersDepartment of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; Integrative Physiology and Metabolism, Joslin Diabetes Center, and.
Jun ShirakawaSections of Islet Cell and Regenerative Biology and Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA;
Tomozumi TakataniSections of Islet Cell and Regenerative Biology and Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA;
Jiang HuSections of Islet Cell and Regenerative Biology and Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA;
Dario F De JesusSections of Islet Cell and Regenerative Biology and Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA;
Rebecca WindmuellerSections of Islet Cell and Regenerative Biology and Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA;
Amy J WagersSections of Islet Cell and Regenerative Biology and Howard Hughes Medical Institute, Department of Stem Cell and Regenerative Biology, Harvard Stem Cell Institute, Harvard University, Cambridge, Massachusetts, USA.
Rohit N KulkarniSections of Islet Cell and Regenerative Biology and Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; rohit.kulkarni@joslin.harvard.edu.
Harvard University · USBrigham and Women's Hospital · USHarvard Stem Cell Institute · USHoward Hughes Medical Institute · US

Funding

SPECIAL ASSAY COREP30DK036836 · NIDDK · JOSLIN DIABETES CENTER · PI JEAN E. SCHAFFER · 1986 to 2026
$50.5M
Role of IGF-1 and Insulin Receptors Beta-Cell SurvivalR01DK067536 · NIDDK · JOSLIN DIABETES CENTER · PI ROHIT N. KULKARNI · 2004 to 2026
$8.0M
NIDDK NIH HHS 5 P30 DK036836-27NIDDK NIH HHS P30 DK036836NIDDK NIH HHS R01 DK067536NIDDK NIH HHS R01 DK67536
6 · The paper itself

Abstract

unlabelledThe impact of somatic cell proliferation rate on induction of pluripotent stem cells remains controversial. Herein, we report that rapid proliferation of human somatic fibroblasts is detrimental to reprogramming efficiency when reprogrammed using a lentiviral vector expressing OCT4, SOX2, KLF4, and cMYC in insulin-rich defined medium. Human fibroblasts grown in this medium showed higher proliferation, enhanced expression of insulin signaling and cell cycle genes, and a switch from glycolytic to oxidative phosphorylation metabolism, but they displayed poor reprogramming efficiency compared with cells grown in normal medium. Thus, in contrast to previous studies, our work reveals an inverse correlation between the proliferation rate of somatic cells and reprogramming efficiency, and also suggests that upregulation of proteins in the growth factor signaling pathway limits the ability to induce pluripotency in human somatic fibroblasts. SIGNIFICANCE: The efficiency with which human cells can be reprogrammed is of interest to stem cell biology. In this study, human fibroblasts cultured in media containing different concentrations of growth factors such as insulin and insulin-like growth factor-1 exhibited variable abilities to proliferate, with consequences on pluripotency. This occurred in part because of changes in the expression of proteins involved in the growth factor signaling pathway, glycolysis, and oxidative phosphorylation. These findings have implications for efficient reprogramming of human cells.

Indexed as

Cellular Reprogramming TechniquesCell DivisionCell HypoxiaCells, CulturedCulture MediaFibroblastsGenes, cdcGlycolysisHumansInduced Pluripotent Stem CellsInsulinIntercellular Signaling Peptides and ProteinsKruppel-Like Factor 4Oxidative PhosphorylationSignal TransductionCulture MediaInsulinIntercellular Signaling Peptides and ProteinsKLF4 protein, humanKruppel-Like Factor 4Cell proliferationHuman pluripotencyInsulin signalingReprogramming

Identifiers

PMID26253715
PMCPMC4572895
OpenAlexW2106433934

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.